Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

The microbiome in bronchiectasis.

Richardson H, Dicker AJ, Barclay H, Chalmers JD.

Eur Respir Rev. 2019 Sep 4;28(153). pii: 190048. doi: 10.1183/16000617.0048-2019. Print 2019 Sep 30.

2.

Pregnancy Zone Protein is Associated with Airway Infection, Neutrophil Extracellular Trap Formation and Disease Severity in Bronchiectasis.

Finch S, Shoemark A, Dicker AJ, Keir HR, Smith A, Ong S, Tan B, Choi JY, Fardon TC, Cassidy D, Huang JTJ, Chalmers JD.

Am J Respir Crit Care Med. 2019 Jul 2. doi: 10.1164/rccm.201812-2351OC. [Epub ahead of print]

PMID:
31264895
3.

Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition.

Keir HR, Fong CJ, Crichton ML, Barth P, Chevalier E, Brady G, Kennedy G, Zimmermann J, Bruijnzeel PLB, Dicker AJ, Chalmers JD.

ERJ Open Res. 2019 Mar 25;5(1). pii: 00252-2018. doi: 10.1183/23120541.00252-2018. eCollection 2019 Feb.

4.

Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD.

Dicker AJ, Crichton ML, Cassidy AJ, Brady G, Hapca A, Tavendale R, Einarsson GG, Furrie E, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

Thorax. 2018 Jun;73(6):510-518. doi: 10.1136/thoraxjnl-2016-209931. Epub 2017 Nov 3.

5.

Profile of the ProAxsis active neutrophil elastase immunoassay for precision medicine in chronic respiratory disease.

Keir HR, Fong CJ, Dicker AJ, Chalmers JD.

Expert Rev Mol Diagn. 2017 Oct;17(10):875-884. doi: 10.1080/14737159.2017.1374174. Epub 2017 Sep 7.

PMID:
28854829
6.

The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?

Finch S, Keir HR, Dicker AJ, Chalmers JD.

Respirology. 2017 Aug;22(6):1062-1072. doi: 10.1111/resp.13106. Epub 2017 Jun 28. Review.

7.

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.

Dicker AJ, Crichton ML, Pumphrey EG, Cassidy AJ, Suarez-Cuartin G, Sibila O, Furrie E, Fong CJ, Ibrahim W, Brady G, Einarsson GG, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

J Allergy Clin Immunol. 2018 Jan;141(1):117-127. doi: 10.1016/j.jaci.2017.04.022. Epub 2017 May 13.

8.

Microbial Dysbiosis in Bronchiectasis and Cystic Fibrosis.

Dicker AJ, Chalmers JD.

Arch Bronconeumol. 2017 Sep;53(9):471-472. doi: 10.1016/j.arbres.2016.11.018. Epub 2017 Jan 6. English, Spanish. No abstract available.

9.

Proteomic analysis of Mecistocirrus digitatus and Haemonchus contortus intestinal protein extracts and subsequent efficacy testing in a vaccine trial.

Dicker AJ, Inglis NF, Manson ED, Subhadra S, Illangopathy M, Muthusamy R, Knox DP.

PLoS Negl Trop Dis. 2014 Jun 5;8(6):e2909. doi: 10.1371/journal.pntd.0002909. eCollection 2014 Jun.

10.

Novel expression of Haemonchus contortus vaccine candidate aminopeptidase H11 using the free-living nematode Caenorhabditis elegans.

Roberts B, Antonopoulos A, Haslam SM, Dicker AJ, McNeilly TN, Johnston SL, Dell A, Knox DP, Britton C.

Vet Res. 2013 Dec 1;44:111. doi: 10.1186/1297-9716-44-111.

11.

Gene expression changes in a P-glycoprotein (Tci-pgp-9) putatively associated with ivermectin resistance in Teladorsagia circumcincta.

Dicker AJ, Nisbet AJ, Skuce PJ.

Int J Parasitol. 2011 Aug 1;41(9):935-42. doi: 10.1016/j.ijpara.2011.03.015. Epub 2011 May 31.

PMID:
21683705
12.

Teladorsagia circumcincta: the transcriptomic response of a multi-drug-resistant isolate to ivermectin exposure in vitro.

Dicker AJ, Nath M, Yaga R, Nisbet AJ, Lainson FA, Gilleard JS, Skuce PJ.

Exp Parasitol. 2011 Feb;127(2):351-6. doi: 10.1016/j.exppara.2010.08.019. Epub 2010 Sep 19.

PMID:
20816955
13.

Alterations in gene expression and activity during squamous cell carcinoma development.

Serewko MM, Popa C, Dahler AL, Smith L, Strutton GM, Coman W, Dicker AJ, Saunders NA.

Cancer Res. 2002 Jul 1;62(13):3759-65.

14.

Isolation (from a basal cell carcinoma) of a functionally distinct fibroblast-like cell type that overexpresses Ptch.

Dicker AJ, Serewko MM, Russell T, Rothnagel JA, Strutton GM, Dahler AL, Saunders NA.

J Invest Dermatol. 2002 May;118(5):859-65.

15.

Histone deacetylase inhibitors: novel anticancer agents.

Saunders NA, Popa C, Serewko MM, Jones SJ, Dicker AJ, Dahler AL.

Expert Opin Investig Drugs. 1999 Oct;8(10):1611-1621.

PMID:
11139814
16.

Functional characterization of cultured cells derived from an intraepidermal carcinoma of the skin (IEC-1).

Dicker AJ, Serewko MM, Dahler AL, Khanna KK, Kaur P, Li A, Strutton GM, Saunders NA.

Exp Cell Res. 2000 Aug 1;258(2):352-60.

PMID:
10896786
17.

E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes.

Dicker AJ, Popa C, Dahler AL, Serewko MM, Hilditch-Maguire PA, Frazer IH, Saunders NA.

Oncogene. 2000 Jun 8;19(25):2887-94.

18.

Cytochrome P450, CYP26AI, is expressed at low levels in human epidermal keratinocytes and is not retinoic acid-inducible.

Popa C, Dicker AJ, Dahler AL, Saunders NA.

Br J Dermatol. 1999 Sep;141(3):460-8.

PMID:
10583049
19.

Keratinocyte growth arrest is associated with activation of a transcriptional repressor element in the human cdk1 promoter.

Dahler AL, Jones SJ, Dicker AJ, Saunders NA.

J Cell Physiol. 1998 Dec;177(3):474-82.

PMID:
9808155
20.

Amelanotic lentigo maligna and amelanotic lentigo maligna melanoma: a report of three cases mimicking intraepidermal squamous carcinoma.

Allan SJ, Dicker AJ, Tidman MJ, McLaren KM, Hunter JA.

J Eur Acad Dermatol Venereol. 1998 Jul;11(1):78-81.

PMID:
9731974
21.
22.

E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.

Jones SJ, Dicker AJ, Dahler AL, Saunders NA.

J Invest Dermatol. 1997 Aug;109(2):187-93.

Supplemental Content

Loading ...
Support Center